OTUD6A in tubular epithelial cells mediates Angiotensin II-induced kidney injury by targeting STAT3

Kidney fibrosis is a prominent pathological feature of hypertensive kidney diseases (HKD). Recent studies have highlighted the role of ubiquitinating/deubiquitinating protein modification in kidney pathophysiology. Ovarian tumor Domain-Containing Protein 6A (OTUD6A) is a deubiquitinating Enzyme involved in tumor progression. However, its role in kidney pathophysiology remains elusive. We aimed to investigate the role and underlying mechanism of OTUD6A during kidney fibrosis in HKD. The results revealed higher OTUD6A expression in kidney tissues of nephropathy patients and mice with chronic Ang II administration than that from the control ones. OTUD6A was mainly located in tubular epithelial cells. Moreover, OTUD6A deficiency significantly protected mice against Ang II-induced kidney dysfunction and fibrosis. Also, knocking OTUD6A down suppressed Ang II-induced fibrosis in cultured tubular epithelial cells, while overexpression of OTUD6A enhanced fibrogenic responses. Mechanistically, OTUD6A bounded to STAT3 and removed K63 linked- ubiquitin chains to promote STAT3 phosphorylation at tyrosine705 position and nuclear translocation, which then induced pro-fibrotic gene transcription in epithelial cells. These studies identified STAT3 as a direct substrate of OTUD6A and highlighted the pivotal role of OTUD6A in Ang II-induced kidney injury, indicating OTUD6A as a potential therapeutic target for HKD.

OTUD6A; STAT3; deubiquitinase; hypertensive kidney diseases; tubular epithelial cells.